INS and Hypoglycemia: Across baseline insulin regimen subsets, reported hypoglycemia (<70 mg/dl) at baseline vs. at study completion, respectively, was 23% vs. 19% for the basal only cohort; 46% vs. 33% for the basal-bolus cohort; and 38% vs. 23% for the premix cohort.